WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke THERAMAP wurde als Wortmarke am 07.11.2017 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1382758 |
| Länder | 
|
| Basismarke |
Nr. 87455849,
18. Mai 2017
|
| Anmeldedatum | 07. November 2017 |
| Ablaufdatum | 07. November 2027 |
Markeninhaber
36 South State Street, Suite 2200
Salt Lake City UT 84111
US
Salt Lake City UT 84111
US
Markenvertreter
201 South Main Street,
Suite 1100
US
Waren und Dienstleistungen
44
Dispensing of pharmaceuticals; medical and pharmaceutical
consultation; pharmaceutical advice; pharmaceutical
compounding services; providing information relating to
diagnostic, prophylactic and therapeutic properties of
pharmaceuticals; medical services, namely, providing
personalized drug therapy management programs to cancer
patients based on the patient's genetic testing results;
genetic testing for medical purposes; genetic testing for
cancer diagnosis, treatment and prevention purposes;
providing genetic sequencing and consulting services via
website designed to provide cancer patients and oncologists
with custom tailored information about the range of possible
treatments and drug therapies for a particular cancer;
providing information to patients and physicians via a
website to recommend cancer treatment and drug therapies
based on the patient's genetic testing results; providing
personalized drug therapy services for cancer patients; drug
utilization review dispensing services via a website,
namely, identifying cancer drug therapies based on a
patient's genetic testing results prior to dispensing
medications; developing and managing comprehensive treatment
programs involving drug therapy; physician support services
in the nature of providing consultation in the dispensing of
prescription drugs for persons with particular cancers;
providing medical evaluations of patients to determine
acceptability for participation in clinical trials;
providing healthcare counseling, screening, diagnosis,
prognosis, treatment, relapse, palliative, integrative
medicine, survivorship, and other related medical
information in the field of oncology; providing a database
in the field of oncology and featuring inputting and
collection of data and information all for treatment and
diagnosis purposes; healthcare consultation in the field of
cancer treatment research, namely, advising patients on
cancer treatment research studies in which they might
participate for purposes of treating their conditions;
providing an online searchable database in the fields of
oncology, bioinformatics, clinical information technology,
genomic data and genomic sequence analysis for personalized
diagnosis, treatment and prevention of cancer
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 07. Februar 2019 | 2019/7 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 13. November 2018 | 2018/46 Gaz | CN | Ablehnung |
| 29. Oktober 2018 | 2018/44 Gaz | KR | Ablehnung |
| 29. September 2018 | 2018/52 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 16. August 2018 | 2018/33 Gaz | JP | Ablehnung |
| 06. Juni 2018 | 2018/23 Gaz | EM | Ablehnung |
| 12. Mai 2018 | 2018/21 Gaz | SG | Ablehnung |
| 10. April 2018 | 2018/15 Gaz | GB | Ablehnung |
| 07. November 2017 | 2017/51 Gaz | US | Eintragung |
ID: 141382758